Russell Investments »

An2 Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2026-06-30 $10k 2.1k 4.84

More positions owned by Russell Investments

Nvidia Corp Common stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Micron Technology Common Stock (MU)
Taiwan Semiconductor Manufacturing Company Common Stock (TSM)
Meta Platforms Common Stock (META)
Mastercard Incorporated Common Stock (MA)
Advanced Micro Devices Common Stock (AMD)
Eli Lilly And Company Common Stock (LLY)
Tesla Common Stock (TSLA)
Applied Materials Common Stock (AMAT)

View all positions for Russell Investments

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
BlackRock
Spruce Street Capital
Almitas Capital
Vanguard Capital Management
Adage Capital Partners GP
Citadel Advisors
Boxer Capital Management
Geode Capital Management
SummitTX Capital
Balyasny Asset Management
Stonepine Capital Management
Ameriprise Financial

View all funds holding An2 Therapeutics